Activity OverviewThe Pediatric Rheumatology Symposium (PRSYM) Highlights will provide up-to-date, practical clinical information and basic science knowledge on the diagnosis and management of pediatric patients with rheumatic diseases and immune disorders.TopicsAddressing Key Issues in Pediatric Rheumatology My Life as a History Lesson and a Call to ActionCourtney Wells, PhD, MPH, MSWA Different World—Viewing Pediatric Rheumatology through a Global LensLaura Lewandowski, MD, MSc Minding the Gap: Understanding and Addressing Representativeness and Disparities in Pediatric Rheumatology ResearchJennifer Woo, PhD, MPHGeneral Pediatric and Subspecialty Workforce Challenges and Potential SolutionsSpeaker: Colleen Correll, MD, MPHPanel DiscussionCourtney Wells, PhD, MPH, MSW; Laura Lewandowski, MD, MSc; Jennifer Woo, PhD, MPH; Colleen Correll, MD, MPHClinical ManagementHarnessing AIBella Mehta, MDFrom Promise to Practice: The Evolving Biosimilar Landscape in Pediatric RheumatologyIngrid Pan, PharmDWhat Do We Know About Vaccinations in Kids with Inflammatory Rheumatic Diseases?Merav Heshin-Bekenstein, MDSystemic Lupus ErythematosusPediatric Antiphospholipid Syndrome: A Few Bad aPLsJacqueline Madison, MDHitting the Target: Optimizing Outcomes in Childhood LupusEve Smith, MD, PhD, BSc Multitarget Therapy is Necessary for the Treatment of cSLE: A Great DebateHermine Brunner, MD, MSc, MBA, FAAP, FACR; and Aimee Hersh, MD, MSJuvenile Idiopathic ArthritisNot So Silent After All—Demystifying the Temporomandibular JointMarinka Twilt, MD, PhD, MSc From Clues to Clarity: Axial Disease in Juvenile SpondyloarthritisPam Weiss, MDImaging as a Biomarker: Peripheral Joint Insights in JIAPatricia Vega-Fernandez, MD, RhMSUS, MSc Panel DiscussionPam Weiss, MD; Marinka Twilt, MD, PhD, MSc; Patricia Vega-Fernandez, MD, RhMSUS, MScClinical Update - Guidlines & RecommendationsUveitis: Clinical Trials & PROsSheila Angeles Han, MD, MSc Mental Health Guidance StatementsTamar Rubinstein, MD, MS Juvenile Dermatomyositis and Scleroderma Let’s Strengthen our Research in JDM: How to Perform and Collect Critical Measures in Clinical PracticeKaveh Ardalan, MD, MS; Stacey Tarvin, MD, MS, FACR; Amy Rakestraw, PT, MPHGuidance for Stem Cell Therapy for Juvenile Systemic Sclerosis PatientsKathryn Torok, MDVasculitisAdvancing Pediatric ANCA-Associated Vasculitis: Insights from Collaborative Research and Emerging Clinical DataJessica Bloom, MD, MSRenal Disease and Risk Stratification in Pediatric ANCA-associated Vasculitis (AAV)—Insights from the Pediatric Vasculitis InitiativeKelly Brown, PhDQI/ImplementationHow to Integrate Data Elements into Clinical Care and Decision MakingDanielle Bullock, MD, MPHTransition ReadinessMelissa Argraves, MD, MEdPR-COIN: Improving JIA OutcomesJulia Harris, MDMental Health ScreeningMileka Gilbert, MD, PhDPanel DiscussionDanielle Bullock, MD, MPH; Melissa Argraves, MD, MEd; Julia Harris, MD; Mileka Gilbert, MD, PhDSystemic Juvenile Idiopathic ArthritisStill's Disease—EULAR/PReS Recommendations Fabrizio De Benedetti, MD, PhDIL-18 InflammosopathyScott Canna, MDCAR-T Therapy: European ExperienceFabrizio De Benedetti, MD, PhDSituational Awareness for New Passengers in the CAR(-T)Christen Ebens, MD, MPHTarget AudienceRheumatologists, rheumatology interprofessionals, fellows in training, and residents.Registration is discounted for ACR/ARP members. If you are not a member, consider joining ACR/ARP.Learning ObjectivesUpon completion of this activity, participants should be able to: Discuss the most up-to-date clinical information on the diagnosis and management of pediatric patients with rheumatic and immunologic disordersDescribe the most current information regarding the pathophysiology underlying pediatric rheumatic disordersCE & MOC InformationIn support of improving patient care, the American College of Rheumatology (ACR) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.See the ACR’s CE Mission Statement. For more information, download the AMA PRA Booklet.Available CreditAMA PRA Category 1 Credit(s)™: 13.00ABIM MOC: 13.00ABP MOC: 13.00ACCME Designation StatementThe American College of Rheumatology designates this enduring material for a maximum of 13.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.MOCAfter submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for diplomates to the diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the Physician Portals. Please allow at least 48 hours for points to display in the portal. MOC Recognition Statement: American Board of Internal Medicine (ABIM)Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board. MOC Recognition Statement: American Board of Pediatrics (ABP)Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 13.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.Financial Relationship DisclosuresACR Disclosure StatementIt is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.Nature of Financial RelationshipsAll individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:Advisor or review panel memberConsultantEmployeeOfficer or Board MemberGrant/research supportSpeaker/honoraria includes speaker’s bureau, symposia, and expert witnessIndependent contractorExecutive role and/or ownership interestRoyalties and/or patent beneficiaryIntellectual property/patentsStock options or bond holdings in a for-profit corporation or self-directed pension planPrivate investigatorExpert witnessEquity interestOther: specify detailsNone: Has no relevant financial relationship(s) with ineligible companies to disclose.All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. PRSYM Highlights 2026 Financial Relationship DisclosuresAcknowledgement of Commercial SupportNo commercial support was provided for this activity.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.

Activity OverviewRheum2Learn 2.0 is case-based fundamental clinical rheumatology education for residents. Each interactive activity includes three patient cases that focus on the care and assessment of individuals with rheumatologic diseases. The included activities use interactive patient cases to simulate clinical scenarios commonly encountered in primary care, inpatient, and critical care settings. Learners are guided to recognize disease patterns, build differential diagnoses, select appropriate tests, and develop treatment strategies in collaboration with rheumatology specialists. Key topics span rheumatoid arthritis, lupus, crystalline arthritis, osteoarthritis, myopathies, systemic sclerosis, pediatric rheumatology, infectious arthritis, osteoporosis, and vasculitis. See below for a complete list of the 15 included activities.Rheum2Learn SeriesThis activity is part of a series. See the other activities in the series below.Rheum2Learn 2.0: Crystalline ArthritisRheum2Learn 2.0: Infectious ArthritisRheum2Learn 2.0: Inflammatory MyopathiesRheum2Learn 2.0: Musculoskeletal DisordersRheum2Learn 2.0: Musculoskeletal ExaminationRheum2Learn 2.0: OsteoporosisRheum2Learn 2.0: OsteoarthritisRheum2Learn 2.0: Pediatric RheumatologyRheum2Learn 2.0: Rheumatic Manifestations of Systemic DiseaseRheum2Learn 2.0: Rheumatoid ArthritisRheum2Learn 2.0: Sjögren’s DiseaseRheum2Learn 2.0: SpondyloarthritisRheum2Learn 2.0: Systemic Lupus ErythematosusRheum2Learn 2.0: Systemic SclerosisRheum2Learn 2.0: Systemic VasculitisRegistration is complimentary.Target AudienceResidents in training who may provide care for patients with rheumatic diagnoses in primary care, inpatient, critical care, and other clinical contexts.The activity may also be of interest to medical students, fellows in training, advanced practice providers, practicing physicians, and other health care professionals who seek to strengthen their clinical knowledge of rheumatic diseases.Learning ObjectivesUpon completion of this activity, participants should be able to:Recognize disease patterns using clinical data and patient history.Formulate a comprehensive differential diagnosis based on disease patterns and diagnostic clues.Select appropriate diagnostic tests and labs to narrow down the diagnosis.Develop treatment strategies in collaboration with rheumatology specialists.See individual activities (linked above) for activity-specific learning objectives. CE & MOC InformationThis activity is not eligible for CME/MOC.Acknowledgement of Commercial SupportRheum2Learn 2.0: Inflammatory Myopathies, Rheum2Learn 2.0: Systemic Lupus Erythematosus, Rheum2Learn 2.0: Pediatric Rheumatology, Rheum2Learn 2.0: Rheumatic Manifestations of Systemic Disease, Rheum2Learn 2.0: Sjögren’s DiseaseThese projects were supported by grant number 1 NU58DP006908-01-00 – Component A: Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services, Centers for Disease Control and Prevention.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.